Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoff Macintyre

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Plos One|April 8, 2014
Curated microRNAs in urine and blood fail to validate as predictive biomarkers for high-risk prostate cancerNikhil Sapre, Matthew K H Hong, Geoff Macintyre, et al.
Nature Communications|December 9, 2022
Author Correction: Inferring structural variant cancer cell fractionMarek Cmero, Ke Yuan, Cheng Soon Ong, et al.
Endocrine-Related Cancer|March 30, 2018
Periprostatic fat tissue transcriptome reveals a signature diagnostic for high-risk prostate cancerStefano Mangiola, Ryan Stuchbery, Geoff Macintyre, et al.
Bioinformatics (Oxford, England)|January 7, 2014
Socrates: identification of genomic rearrangements in tumour genomes by re-aligning soft clipped readsJan Schröder, Arthur Hsu, Samantha E Boyle, et al.
BMC Genomics|January 23, 2014
Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 arrayHaroon Naeem, Nicholas C Wong, Zac Chatterton, et al.
Scientific Reports|September 23, 2016
Comparing nodal versus bony metastatic spread using tumour phylogeniesStefano Mangiola, Matthew K H Hong, Marek Cmero, et al.
British Journal of Cancer|January 27, 2016
A urinary microRNA signature can predict the presence of bladder urothelial carcinoma in patients undergoing surveillanceNikhil Sapre, Geoff Macintyre, Michael Clarkson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2014
Canonical androstenedione reduction is the predominant source of signaling androgens in hormone-refractory prostate cancerMatthew Fankhauser, Yuen Tan, Geoff Macintyre, et al.
Clinical & Experimental Metastasis|October 3, 2013
Percutaneous image-guided biopsy of prostate cancer metastases yields samples suitable for genomics and personalised oncologyMatthew K H Hong, Nikhil Sapre, Pramit M Phal, et al.
JCO Clinical Cancer Informatics|February 11, 2021
FrenchFISH: Poisson Models for Quantifying DNA Copy Number From Fluorescence In Situ Hybridization of Tissue SectionsGeoff Macintyre, Anna M Piskorz, Adam Berman, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Plos One|April 8, 2014
Curated microRNAs in urine and blood fail to validate as predictive biomarkers for high-risk prostate cancerNikhil Sapre, Matthew K H Hong, Geoff Macintyre, et al.
Nature Communications|December 9, 2022
Author Correction: Inferring structural variant cancer cell fractionMarek Cmero, Ke Yuan, Cheng Soon Ong, et al.
Endocrine-Related Cancer|March 30, 2018
Periprostatic fat tissue transcriptome reveals a signature diagnostic for high-risk prostate cancerStefano Mangiola, Ryan Stuchbery, Geoff Macintyre, et al.
Bioinformatics (Oxford, England)|January 7, 2014
Socrates: identification of genomic rearrangements in tumour genomes by re-aligning soft clipped readsJan Schröder, Arthur Hsu, Samantha E Boyle, et al.
BMC Genomics|January 23, 2014
Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 arrayHaroon Naeem, Nicholas C Wong, Zac Chatterton, et al.
Scientific Reports|September 23, 2016
Comparing nodal versus bony metastatic spread using tumour phylogeniesStefano Mangiola, Matthew K H Hong, Marek Cmero, et al.
British Journal of Cancer|January 27, 2016
A urinary microRNA signature can predict the presence of bladder urothelial carcinoma in patients undergoing surveillanceNikhil Sapre, Geoff Macintyre, Michael Clarkson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2014
Canonical androstenedione reduction is the predominant source of signaling androgens in hormone-refractory prostate cancerMatthew Fankhauser, Yuen Tan, Geoff Macintyre, et al.
Clinical & Experimental Metastasis|October 3, 2013
Percutaneous image-guided biopsy of prostate cancer metastases yields samples suitable for genomics and personalised oncologyMatthew K H Hong, Nikhil Sapre, Pramit M Phal, et al.
JCO Clinical Cancer Informatics|February 11, 2021
FrenchFISH: Poisson Models for Quantifying DNA Copy Number From Fluorescence In Situ Hybridization of Tissue SectionsGeoff Macintyre, Anna M Piskorz, Adam Berman, et al.
Pageof 5